Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Immunology|August 6, 2000
gammadelta T-cell anergy in human immunodeficiency virus-infected persons with opportunistic infections and recovery after highly active antiretroviral therapyF Martini, R Urso, C Gioia, et al.
Annals of the New York Academy of Sciences|January 5, 2002
Metabolic and morphologic disorders in patients treated with highly active antiretroviral therapy since primary HIV infectionP Narciso, V Tozzi, G D'Offizi, et al.
Pharmacology, Biochemistry, and Behavior|January 18, 2005
Estradiol valerate and intake of sweetened waterKaren J Boswell, Meta L Reid, Jessica V Fitch, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 25, 2010
Analysis of co-receptor usage of circulating viral and proviral HIV genome quasispecies by ultra-deep pyrosequencing in patients who are candidates for CCR5 antagonist treatmentI Abbate, G Rozera, C Tommasi, et al.
AIDS (London, England)|May 1, 1993
Effects of zidovudine in 30 patients with mild to end-stage AIDS dementia complexV Tozzi, P Narciso, S Galgani, et al.
AIDS Research and Human Retroviruses|January 10, 2002
Decay of HIV type 1 DNA and development of drug-resistant mutants in patients with primary HIV type 1 infection receiving highly active antiretroviral therapyE Riva, M Pistello, P Narciso, et al.
Journal of Biological Regulators and Homeostatic Agents|September 24, 2005
CD1d expression by hepatocytes is a main restriction element for intrahepatic T-cell recognitionC Agrati, F Martini, C Nisii, et al.
Infection|March 11, 2009
Effect of suppressing HIV viremia on the HIV progression of patients undergoing a genotype resistance test after treatment failureM Zaccarelli, P Lorenzini, V Tozzi, et al.
Annals of Diagnostic Pathology|December 14, 1999
Human herpesvirus-8 in lymphomatous and nonlymphomatous body cavity effusions developing in Kaposi's sarcoma and multicentric Castleman's diseaseV Ascoli, M C Sirianni, I Mezzaroma, et al.
AIDS (London, England)|October 8, 1999
Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairmentV Tozzi, P Balestra, S Galgani, et al.
Pageof 6